Abdalian replaces Rogers as CFO at BG Medicine
This article was originally published in Clinica
Executive Summary
BG Medicine, a company developing novel cardiovascular diagnostics, has appointed Charles Abdalian executive vice-president and CFO, replacing Michael Rogers who is leaving the company. Mr Abdalian has over 30 years' experience in healthcare corporate finance and strategic management, having most recently served as vice-president and CFO of Knome, a bioinformatics company.